Earningsstocks🟠 Score 8AI Generated

Regeneron Pharmaceuticals Reports Strong Q1 2026 Earnings Beat

By rawfin.tv Markets Desk|April 30, 2026, 01:03 UTC|1 min read|AI-assisted · Methodology

Regeneron Pharmaceuticals (REGN) announced robust first-quarter 2026 earnings, surpassing both analyst expectations for EPS and revenue. The strong performance indicates positive momentum for the biotechnology firm.

RegeneronEarnings BeatBiotechnologyPharmaceuticalsQ1 Results

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks9h ago

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks12h ago

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks17h ago

Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

stocks18h ago